APC-001

N/A

Report date: 2025/02/12 14:53:46
NME

Base Information

Drug NameAPC-001
Drug Alias NameAPC-001
ClassificationSmall molecules > Nucleosides and nucleotide derivtives
Mechanisms of ActionSclerostin inhibitors
TargetsSclerostin
Therapy Area/IndicationsOsteogenesis Imperfecta
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryHong Kong
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesAptacure Therapeutics Ltd
China Registration ClassN/A

Develop Information

Active CompaniesAptacure Therapeutics Ltd
Inactive CompaniesN/A
Active IndicationsOsteogenesis Imperfecta
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A